title: Can intimal hyperplasia and distal anastomotic intimal hyperplasia be controlled and prevented?
authors.affiliation: Advocate General Lutheran Hospital, Park Ridge, Illinois 60068, USA. sottiuraiv@comcast.net
authors.forename: V S
authors.initials: VS
authors.lastname: Sottiurai
mesh_terms: D000714:Anastomosis, Surgical / Q000009:adverse effects; D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D016207:Cytokines / Q000187:drug effects / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D006801:Humans; D006965:Hyperplasia / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D017539:Tunica Intima / Q000378:metabolism / Q000473:pathology*; D014652:Vascular Diseases / Q000209:etiology / Q000517:prevention & control*; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
chemical_list: D016207:Cytokines; D036341:Intercellular Signaling Peptides and Proteins; D010975:Platelet Aggregation Inhibitors